caffeine citrate has been researched along with Disease Models, Animal in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Abrams, RPM; Bachani, M; Balasubramanian, A; Brimacombe, K; Dorjsuren, D; Eastman, RT; Hall, MD; Jadhav, A; Lee, MH; Li, W; Malik, N; Nath, A; Padmanabhan, R; Simeonov, A; Steiner, JP; Teramoto, T; Yasgar, A; Zakharov, AV | 1 |
| Catland, D; Coalson, JJ; Martin, H; Siler-Khodr, TM; Thomson, MA; Winter, VT; Yoder, BA | 1 |
| Coalson, J; Thomson, M; Yoder, B | 1 |
3 other study(ies) available for caffeine citrate and Disease Models, Animal
| Article | Year |
|---|---|
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
Topics: Animals; Antiviral Agents; Artificial Intelligence; Chlorocebus aethiops; Disease Models, Animal; Drug Evaluation, Preclinical; High-Throughput Screening Assays; Immunocompetence; Inhibitory Concentration 50; Methacycline; Mice, Inbred C57BL; Protease Inhibitors; Quantitative Structure-Activity Relationship; Small Molecule Libraries; Vero Cells; Zika Virus; Zika Virus Infection | 2020 |
Treatment of immature baboons for 28 days with early nasal continuous positive airway pressure.
Topics: Age Factors; Animals; Animals, Newborn; Biological Products; Biopsy; Bronchoalveolar Lavage Fluid; Bronchopulmonary Dysplasia; Caffeine; Cesarean Section; Citrates; Combined Modality Therapy; Continuous Positive Airway Pressure; Disease Models, Animal; Drug Combinations; Feasibility Studies; Humans; Infant, Newborn; Intensive Care, Neonatal; Lung; Papio; Parenteral Nutrition, Total; Phospholipids; Pulmonary Gas Exchange; Risk Factors; Time Factors; Ventilator Weaning | 2004 |
Lung function in immature baboons with respiratory distress syndrome receiving early caffeine therapy: a pilot study.
Topics: Animals; Animals, Newborn; Biological Products; Bronchodilator Agents; Caffeine; Citrates; Continuous Positive Airway Pressure; Disease Models, Animal; Drug Combinations; Female; Humans; Infant, Newborn; Lung; Male; Papio; Phospholipids; Pilot Projects; Pulmonary Surfactants; Respiratory Distress Syndrome, Newborn; Respiratory Function Tests; Respiratory Mechanics; Treatment Outcome | 2005 |